 | • レポートコード：MRC2-11QY00130 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はシャーガス病治療薬のグローバル市場について調査・分析したレポートです。種類別（Cz-007、Cz-008、D-121、DNDI-0690、EPLBS-1246、EPLBS-967、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別シャーガス病治療薬の競争状況、市場シェア ・世界のシャーガス病治療薬市場：種類別市場規模 2015年-2020年（Cz-007、Cz-008、D-121、DNDI-0690、EPLBS-1246、EPLBS-967、その他） ・世界のシャーガス病治療薬市場：種類別市場規模予測 2021年-2026年（Cz-007、Cz-008、D-121、DNDI-0690、EPLBS-1246、EPLBS-967、その他） ・世界のシャーガス病治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界のシャーガス病治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米のシャーガス病治療薬市場分析：米国、カナダ ・ヨーロッパのシャーガス病治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのシャーガス病治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のシャーガス病治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのシャーガス病治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AstraZeneca Plc、Bayer AG、Daiichi Sankyo Co Ltd、Eisai Co Ltd、GlaxoSmithKline Plc、Grupo Praxis Pharmaceutical SA、Humanigen Inc、Kancera AB、Merck & Co Inc、Novartis AG、Oblita Therapeutics BVBA、Sanofi ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Chagas Disease Drug Market
The global Chagas Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Chagas Disease Drug Scope and Market Size
Chagas Disease Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chagas Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Chagas Disease Drug market is segmented into
Cz-007
Cz-008
D-121
DNDI-0690
EPLBS-1246
EPLBS-967
Others
Segment by Application, the Chagas Disease Drug market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Chagas Disease Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Chagas Disease Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Chagas Disease Drug Market Share Analysis
Chagas Disease Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Chagas Disease Drug business, the date to enter into the Chagas Disease Drug market, Chagas Disease Drug product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca Plc
Bayer AG
Daiichi Sankyo Co Ltd
Eisai Co Ltd
GlaxoSmithKline Plc
Grupo Praxis Pharmaceutical SA
Humanigen Inc
Kancera AB
Merck & Co Inc
Novartis AG
Oblita Therapeutics BVBA
Sanofi
1 Study Coverage
1.1 Chagas Disease Drug Product Introduction
1.2 Market Segments
1.3 Key Chagas Disease Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Chagas Disease Drug Market Size Growth Rate by Type
1.4.2 Cz-007
1.4.3 Cz-008
1.4.4 D-121
1.4.5 DNDI-0690
1.4.6 EPLBS-1246
1.4.7 EPLBS-967
1.4.8 Others
1.5 Market by Application
1.5.1 Global Chagas Disease Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Chagas Disease Drug Market Size, Estimates and Forecasts
2.1.1 Global Chagas Disease Drug Revenue 2015-2026
2.1.2 Global Chagas Disease Drug Sales 2015-2026
2.2 Global Chagas Disease Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Chagas Disease Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Chagas Disease Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Chagas Disease Drug Competitor Landscape by Players
3.1 Chagas Disease Drug Sales by Manufacturers
3.1.1 Chagas Disease Drug Sales by Manufacturers (2015-2020)
3.1.2 Chagas Disease Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Chagas Disease Drug Revenue by Manufacturers
3.2.1 Chagas Disease Drug Revenue by Manufacturers (2015-2020)
3.2.2 Chagas Disease Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Chagas Disease Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Chagas Disease Drug Revenue in 2019
3.2.5 Global Chagas Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Chagas Disease Drug Price by Manufacturers
3.4 Chagas Disease Drug Manufacturing Base Distribution, Product Types
3.4.1 Chagas Disease Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chagas Disease Drug Product Type
3.4.3 Date of International Manufacturers Enter into Chagas Disease Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Chagas Disease Drug Market Size by Type (2015-2020)
4.1.1 Global Chagas Disease Drug Sales by Type (2015-2020)
4.1.2 Global Chagas Disease Drug Revenue by Type (2015-2020)
4.1.3 Chagas Disease Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Chagas Disease Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Chagas Disease Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Chagas Disease Drug Revenue Forecast by Type (2021-2026)
4.2.3 Chagas Disease Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Chagas Disease Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Chagas Disease Drug Market Size by Application (2015-2020)
5.1.1 Global Chagas Disease Drug Sales by Application (2015-2020)
5.1.2 Global Chagas Disease Drug Revenue by Application (2015-2020)
5.1.3 Chagas Disease Drug Price by Application (2015-2020)
5.2 Chagas Disease Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Chagas Disease Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Chagas Disease Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Chagas Disease Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Chagas Disease Drug by Country
6.1.1 North America Chagas Disease Drug Sales by Country
6.1.2 North America Chagas Disease Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Chagas Disease Drug Market Facts & Figures by Type
6.3 North America Chagas Disease Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Chagas Disease Drug by Country
7.1.1 Europe Chagas Disease Drug Sales by Country
7.1.2 Europe Chagas Disease Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Chagas Disease Drug Market Facts & Figures by Type
7.3 Europe Chagas Disease Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Chagas Disease Drug by Region
8.1.1 Asia Pacific Chagas Disease Drug Sales by Region
8.1.2 Asia Pacific Chagas Disease Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Chagas Disease Drug Market Facts & Figures by Type
8.3 Asia Pacific Chagas Disease Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Chagas Disease Drug by Country
9.1.1 Latin America Chagas Disease Drug Sales by Country
9.1.2 Latin America Chagas Disease Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Chagas Disease Drug Market Facts & Figures by Type
9.3 Central & South America Chagas Disease Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Chagas Disease Drug by Country
10.1.1 Middle East and Africa Chagas Disease Drug Sales by Country
10.1.2 Middle East and Africa Chagas Disease Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Chagas Disease Drug Market Facts & Figures by Type
10.3 Middle East and Africa Chagas Disease Drug Market Facts & Figures by Application
11 Company Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Corporation Information
11.1.2 AstraZeneca Plc Description and Business Overview
11.1.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Plc Chagas Disease Drug Products Offered
11.1.5 AstraZeneca Plc Related Developments
11.2 Bayer AG
11.2.1 Bayer AG Corporation Information
11.2.2 Bayer AG Description and Business Overview
11.2.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bayer AG Chagas Disease Drug Products Offered
11.2.5 Bayer AG Related Developments
11.3 Daiichi Sankyo Co Ltd
11.3.1 Daiichi Sankyo Co Ltd Corporation Information
11.3.2 Daiichi Sankyo Co Ltd Description and Business Overview
11.3.3 Daiichi Sankyo Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Daiichi Sankyo Co Ltd Chagas Disease Drug Products Offered
11.3.5 Daiichi Sankyo Co Ltd Related Developments
11.4 Eisai Co Ltd
11.4.1 Eisai Co Ltd Corporation Information
11.4.2 Eisai Co Ltd Description and Business Overview
11.4.3 Eisai Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Eisai Co Ltd Chagas Disease Drug Products Offered
11.4.5 Eisai Co Ltd Related Developments
11.5 GlaxoSmithKline Plc
11.5.1 GlaxoSmithKline Plc Corporation Information
11.5.2 GlaxoSmithKline Plc Description and Business Overview
11.5.3 GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 GlaxoSmithKline Plc Chagas Disease Drug Products Offered
11.5.5 GlaxoSmithKline Plc Related Developments
11.6 Grupo Praxis Pharmaceutical SA
11.6.1 Grupo Praxis Pharmaceutical SA Corporation Information
11.6.2 Grupo Praxis Pharmaceutical SA Description and Business Overview
11.6.3 Grupo Praxis Pharmaceutical SA Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Products Offered
11.6.5 Grupo Praxis Pharmaceutical SA Related Developments
11.7 Humanigen Inc
11.7.1 Humanigen Inc Corporation Information
11.7.2 Humanigen Inc Description and Business Overview
11.7.3 Humanigen Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Humanigen Inc Chagas Disease Drug Products Offered
11.7.5 Humanigen Inc Related Developments
11.8 Kancera AB
11.8.1 Kancera AB Corporation Information
11.8.2 Kancera AB Description and Business Overview
11.8.3 Kancera AB Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Kancera AB Chagas Disease Drug Products Offered
11.8.5 Kancera AB Related Developments
11.9 Merck & Co Inc
11.9.1 Merck & Co Inc Corporation Information
11.9.2 Merck & Co Inc Description and Business Overview
11.9.3 Merck & Co Inc Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Merck & Co Inc Chagas Disease Drug Products Offered
11.9.5 Merck & Co Inc Related Developments
11.10 Novartis AG
11.10.1 Novartis AG Corporation Information
11.10.2 Novartis AG Description and Business Overview
11.10.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Novartis AG Chagas Disease Drug Products Offered
11.10.5 Novartis AG Related Developments
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Corporation Information
11.1.2 AstraZeneca Plc Description and Business Overview
11.1.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Plc Chagas Disease Drug Products Offered
11.1.5 AstraZeneca Plc Related Developments
11.12 Sanofi
11.12.1 Sanofi Corporation Information
11.12.2 Sanofi Description and Business Overview
11.12.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Sanofi Products Offered
11.12.5 Sanofi Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Chagas Disease Drug Market Estimates and Projections by Region
12.1.1 Global Chagas Disease Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Chagas Disease Drug Revenue Forecast by Regions 2021-2026
12.2 North America Chagas Disease Drug Market Size Forecast (2021-2026)
12.2.1 North America: Chagas Disease Drug Sales Forecast (2021-2026)
12.2.2 North America: Chagas Disease Drug Revenue Forecast (2021-2026)
12.2.3 North America: Chagas Disease Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Chagas Disease Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Chagas Disease Drug Sales Forecast (2021-2026)
12.3.2 Europe: Chagas Disease Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Chagas Disease Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Chagas Disease Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Chagas Disease Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Chagas Disease Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Chagas Disease Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Chagas Disease Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Chagas Disease Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Chagas Disease Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Chagas Disease Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Chagas Disease Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Chagas Disease Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Chagas Disease Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Chagas Disease Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Chagas Disease Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Chagas Disease Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Chagas Disease Drug Market Segments
Table 2. Ranking of Global Top Chagas Disease Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Chagas Disease Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Cz-007
Table 5. Major Manufacturers of Cz-008
Table 6. Major Manufacturers of D-121
Table 7. Major Manufacturers of DNDI-0690
Table 8. Major Manufacturers of EPLBS-1246
Table 9. Major Manufacturers of EPLBS-967
Table 10. Major Manufacturers of Others
Table 11. Global Chagas Disease Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Chagas Disease Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Chagas Disease Drug Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Chagas Disease Drug Sales Market Share by Regions (2015-2020)
Table 15. Global Chagas Disease Drug Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Chagas Disease Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Chagas Disease Drug Sales Share by Manufacturers (2015-2020)
Table 18. Global Chagas Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Chagas Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chagas Disease Drug as of 2019)
Table 20. Chagas Disease Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Chagas Disease Drug Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Chagas Disease Drug Price (2015-2020) (USD/Pcs)
Table 23. Chagas Disease Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Chagas Disease Drug Product Type
Table 25. Date of International Manufacturers Enter into Chagas Disease Drug Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Chagas Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 28. Global Chagas Disease Drug Sales Share by Type (2015-2020)
Table 29. Global Chagas Disease Drug Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Chagas Disease Drug Revenue Share by Type (2015-2020)
Table 31. Chagas Disease Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Chagas Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 33. Global Chagas Disease Drug Sales Share by Application (2015-2020)
Table 34. North America Chagas Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 35. North America Chagas Disease Drug Sales Market Share by Country (2015-2020)
Table 36. North America Chagas Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Chagas Disease Drug Revenue Market Share by Country (2015-2020)
Table 38. North America Chagas Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 39. North America Chagas Disease Drug Sales Market Share by Type (2015-2020)
Table 40. North America Chagas Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 41. North America Chagas Disease Drug Sales Market Share by Application (2015-2020)
Table 42. Europe Chagas Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 43. Europe Chagas Disease Drug Sales Market Share by Country (2015-2020)
Table 44. Europe Chagas Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Chagas Disease Drug Revenue Market Share by Country (2015-2020)
Table 46. Europe Chagas Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 47. Europe Chagas Disease Drug Sales Market Share by Type (2015-2020)
Table 48. Europe Chagas Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 49. Europe Chagas Disease Drug Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Chagas Disease Drug Sales by Region (2015-2020) (K Pcs)
Table 51. Asia Pacific Chagas Disease Drug Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Chagas Disease Drug Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Chagas Disease Drug Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Chagas Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 55. Asia Pacific Chagas Disease Drug Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Chagas Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 57. Asia Pacific Chagas Disease Drug Sales Market Share by Application (2015-2020)
Table 58. Latin America Chagas Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 59. Latin America Chagas Disease Drug Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Chagas Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Chagas Disease Drug Revenue Market Share by Country (2015-2020)
Table 62. Latin America Chagas Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 63. Latin America Chagas Disease Drug Sales Market Share by Type (2015-2020)
Table 64. Latin America Chagas Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 65. Latin America Chagas Disease Drug Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Chagas Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 67. Middle East and Africa Chagas Disease Drug Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Chagas Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Chagas Disease Drug Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Chagas Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 71. Middle East and Africa Chagas Disease Drug Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Chagas Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 73. Middle East and Africa Chagas Disease Drug Sales Market Share by Application (2015-2020)
Table 74. AstraZeneca Plc Corporation Information
Table 75. AstraZeneca Plc Description and Major Businesses
Table 76. AstraZeneca Plc Chagas Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. AstraZeneca Plc Product
Table 78. AstraZeneca Plc Recent Development
Table 79. Bayer AG Corporation Information
Table 80. Bayer AG Description and Major Businesses
Table 81. Bayer AG Chagas Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. Bayer AG Product
Table 83. Bayer AG Recent Development
Table 84. Daiichi Sankyo Co Ltd Corporation Information
Table 85. Daiichi Sankyo Co Ltd Description and Major Businesses
Table 86. Daiichi Sankyo Co Ltd Chagas Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Daiichi Sankyo Co Ltd Product
Table 88. Daiichi Sankyo Co Ltd Recent Development
Table 89. Eisai Co Ltd Corporation Information
Table 90. Eisai Co Ltd Description and Major Businesses
Table 91. Eisai Co Ltd Chagas Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Eisai Co Ltd Product
Table 93. Eisai Co Ltd Recent Development
Table 94. GlaxoSmithKline Plc Corporation Information
Table 95. GlaxoSmithKline Plc Description and Major Businesses
Table 96. GlaxoSmithKline Plc Chagas Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. GlaxoSmithKline Plc Product
Table 98. GlaxoSmithKline Plc Recent Development
Table 99. Grupo Praxis Pharmaceutical SA Corporation Information
Table 100. Grupo Praxis Pharmaceutical SA Description and Major Businesses
Table 101. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. Grupo Praxis Pharmaceutical SA Product
Table 103. Grupo Praxis Pharmaceutical SA Recent Development
Table 104. Humanigen Inc Corporation Information
Table 105. Humanigen Inc Description and Major Businesses
Table 106. Humanigen Inc Chagas Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 107. Humanigen Inc Product
Table 108. Humanigen Inc Recent Development
Table 109. Kancera AB Corporation Information
Table 110. Kancera AB Description and Major Businesses
Table 111. Kancera AB Chagas Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Kancera AB Product
Table 113. Kancera AB Recent Development
Table 114. Merck & Co Inc Corporation Information
Table 115. Merck & Co Inc Description and Major Businesses
Table 116. Merck & Co Inc Chagas Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Merck & Co Inc Product
Table 118. Merck & Co Inc Recent Development
Table 119. Novartis AG Corporation Information
Table 120. Novartis AG Description and Major Businesses
Table 121. Novartis AG Chagas Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 122. Novartis AG Product
Table 123. Novartis AG Recent Development
Table 124. Oblita Therapeutics BVBA Corporation Information
Table 125. Oblita Therapeutics BVBA Description and Major Businesses
Table 126. Oblita Therapeutics BVBA Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 127. Oblita Therapeutics BVBA Product
Table 128. Oblita Therapeutics BVBA Recent Development
Table 129. Sanofi Corporation Information
Table 130. Sanofi Description and Major Businesses
Table 131. Sanofi Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 132. Sanofi Product
Table 133. Sanofi Recent Development
Table 134. Global Chagas Disease Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 135. Global Chagas Disease Drug Sales Market Share Forecast by Regions (2021-2026)
Table 136. Global Chagas Disease Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 137. Global Chagas Disease Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 138. North America: Chagas Disease Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 139. North America: Chagas Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Europe: Chagas Disease Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 141. Europe: Chagas Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Asia Pacific: Chagas Disease Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 143. Asia Pacific: Chagas Disease Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 144. Latin America: Chagas Disease Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 145. Latin America: Chagas Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Middle East and Africa: Chagas Disease Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 147. Middle East and Africa: Chagas Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 149. Key Challenges
Table 150. Market Risks
Table 151. Main Points Interviewed from Key Chagas Disease Drug Players
Table 152. Chagas Disease Drug Customers List
Table 153. Chagas Disease Drug Distributors List
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Chagas Disease Drug Product Picture
Figure 2. Global Chagas Disease Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Cz-007 Product Picture
Figure 4. Cz-008 Product Picture
Figure 5. D-121 Product Picture
Figure 6. DNDI-0690 Product Picture
Figure 7. EPLBS-1246 Product Picture
Figure 8. EPLBS-967 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Chagas Disease Drug Sales Market Share by Application in 2020 & 2026
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Others
Figure 14. Chagas Disease Drug Report Years Considered
Figure 15. Global Chagas Disease Drug Market Size 2015-2026 (US$ Million)
Figure 16. Global Chagas Disease Drug Sales 2015-2026 (K Pcs)
Figure 17. Global Chagas Disease Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Chagas Disease Drug Sales Market Share by Region (2015-2020)
Figure 19. Global Chagas Disease Drug Sales Market Share by Region in 2019
Figure 20. Global Chagas Disease Drug Revenue Market Share by Region (2015-2020)
Figure 21. Global Chagas Disease Drug Revenue Market Share by Region in 2019
Figure 22. Global Chagas Disease Drug Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Chagas Disease Drug Revenue in 2019
Figure 24. Chagas Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Chagas Disease Drug Sales Market Share by Type (2015-2020)
Figure 26. Global Chagas Disease Drug Sales Market Share by Type in 2019
Figure 27. Global Chagas Disease Drug Revenue Market Share by Type (2015-2020)
Figure 28. Global Chagas Disease Drug Revenue Market Share by Type in 2019
Figure 29. Global Chagas Disease Drug Market Share by Price Range (2015-2020)
Figure 30. Global Chagas Disease Drug Sales Market Share by Application (2015-2020)
Figure 31. Global Chagas Disease Drug Sales Market Share by Application in 2019
Figure 32. Global Chagas Disease Drug Revenue Market Share by Application (2015-2020)
Figure 33. Global Chagas Disease Drug Revenue Market Share by Application in 2019
Figure 34. North America Chagas Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Chagas Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Chagas Disease Drug Sales Market Share by Country in 2019
Figure 37. North America Chagas Disease Drug Revenue Market Share by Country in 2019
Figure 38. U.S. Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Chagas Disease Drug Market Share by Type in 2019
Figure 43. North America Chagas Disease Drug Market Share by Application in 2019
Figure 44. Europe Chagas Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Chagas Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Chagas Disease Drug Sales Market Share by Country in 2019
Figure 47. Europe Chagas Disease Drug Revenue Market Share by Country in 2019
Figure 48. Germany Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Chagas Disease Drug Market Share by Type in 2019
Figure 59. Europe Chagas Disease Drug Market Share by Application in 2019
Figure 60. Asia Pacific Chagas Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Chagas Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Chagas Disease Drug Sales Market Share by Region in 2019
Figure 63. Asia Pacific Chagas Disease Drug Revenue Market Share by Region in 2019
Figure 64. China Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Chagas Disease Drug Market Share by Type in 2019
Figure 87. Asia Pacific Chagas Disease Drug Market Share by Application in 2019
Figure 88. Latin America Chagas Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Chagas Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Chagas Disease Drug Sales Market Share by Country in 2019
Figure 91. Latin America Chagas Disease Drug Revenue Market Share by Country in 2019
Figure 92. Mexico Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Chagas Disease Drug Market Share by Type in 2019
Figure 99. Latin America Chagas Disease Drug Market Share by Application in 2019
Figure 100. Middle East and Africa Chagas Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Chagas Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Chagas Disease Drug Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Chagas Disease Drug Revenue Market Share by Country in 2019
Figure 104. Turkey Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Chagas Disease Drug Market Share by Type in 2019
Figure 111. Middle East and Africa Chagas Disease Drug Market Share by Application in 2019
Figure 112. North America Chagas Disease Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Chagas Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Chagas Disease Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Chagas Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Chagas Disease Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Chagas Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Chagas Disease Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Chagas Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Chagas Disease Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Chagas Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
クローン病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Crohn’s Disease Drug Market The global Crohn’s Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Crohn’s Disease Drug Scope and Market Size Crohn’s Disease Drug market is…- ベーチェット病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Behcet Disease Drug Market The global Behcet Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Behcet Disease Drug Scope and Market Size Behcet Disease Drug market is seg…
- シャルコー・マリー・トゥース病IA型治療薬の世界市場（～2026年） Market Analysis and Insights: Global Charcot-Marie-Tooth Disease Type I A Drug Market The global Charcot-Marie-Tooth Disease Type I A Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Charcot-Marie-Tooth Disease Typ…
- 性感染症（STD）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Sexually Transmitted Disease (STD ) Drug Market The global Sexually Transmitted Disease (STD ) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Sexually Transmitted Disease (STD…
- 血管閉塞症・鎌状赤血球症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market The global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-20…